Daniel Greenleaf is in a familiar position. The new president and CEO of BioScrip is tasked with turning around an underperforming home infusion company, which he did with both Coram and, more recently, with Home Solutions.
DENVER – With revenues at BioScrip sliding again in the third quarter, new President and CEO Daniel Greenleaf didn’t mince words on a recent earnings call.
WASHINGTON – As this year’s congressional session winds down, HME stakeholders are eyeing the “doc-fix” bill as the best vehicle for H.R. 1717.
DENVER – Daniel Greenleaf is now president and CEO of specialty-infusion company Home Solutions, the Denver Post reports.
© 2016 United Publications Inc. ALL RIGHTS RESERVED